Bioorganic & Medicinal Chemistry Letters 2009-09-15

Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.

Atsushi Satoh, Yasushi Nagatomi, Yukari Hirata, Satoru Ito, Gentaroh Suzuki, Toshifumi Kimura, Shunsuke Maehara, Hirohiko Hikichi, Akio Satow, Mikiko Hata, Hisashi Ohta, Hiroshi Kawamoto

Index: Bioorg. Med. Chem. Lett. 19(18) , 5464-8, (2009)

Full Text: HTML

Abstract

We identified 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide 27 as a potent mGluR1 antagonist. The compound possessed excellent subtype selectivity and good PK profile in rats. It also demonstrated relatively potent antipsychotic-like effects in several animal models. Suitable for development as a PET tracer, compound 27 would have great potential for elucidation of mGluR1 functions in human.

Related Compounds

  • 1MVR

Related Articles:

Thermodynamic analysis of the binding of aromatic hydroxamic acid analogues to ferric horseradish peroxidase.

2001-11-20

[Biochemistry 40(46) , 13980-9, (2001)]

N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors.

2013-10-01

[Bioorg. Med. Chem. 21(19) , 6053-62, (2013)]

Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptor.

1986-05-01

[J. Med. Chem. 29(5) , 600-6, (1986)]

The formation and metabolism of N-hydroxymethyl compounds--III. The metabolic conversion of N-methyl and N,N,-dimethylbenzamides to N-hydroxymethyl compounds.

1983-06-01

[Biochem. Pharmacol. 32(11) , 1773-81, (1983)]

The microsomal demethylation of N,N-dimethylbenzamides. Substituent and kinetic deuterium isotope effects.

1992-08-18

[Biochem. Pharmacol. 44(4) , 651-8, (1992)]

More Articles...